Ensuring fairness and transparency in the markets of prescription drugs : hearing before the Subcommittee on Consumer Protection, Product Safety, and Data Security of the Committee on Commerce, Science, and Transportation, United States Senate, One Hundred Seventeenth Congress, second session, May 5, 2022.

Author/creator United States
Format Electronic
PublicationWashington : U.S. Government Publishing Office, 2024.
Description1 online resource (iii, 118 pages) : illustrations.
Supplemental Contenthttps://purl.fdlp.gov/GPO/gpo224286
Subjects

SeriesS. hrg. ; 117-836
United States. Congress. Senate. S. hrg. ; https://id.loc.gov/authorities/names/n83707917 ; 117-836. ^A500722
General noteIn scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General noteGPO Cataloging Record Distribution Program (CRDP).
Bibliography noteIncludes bibliographical references.
Date/time/place of a event noteDate of hearing: 2022-05-05.
Source of descriptionDescription based on online resource; title from PDF title page (GovInfo, viewed April 18, 2024).
Issued in other formPrint version: United States. Congress. Senate. Committee on Commerce, Science, and Transportation. Subcommittee on Consumer Protection, Product Safety, and Data Security. Ensuring fairness and transparency in the markets of prescription drugs
Genre/formLegislative hearings.
Standard identifier# 54-763 (GPO jacket number)
GPO item number1041-C (online)
Govt. docs number Y 4.C 73/7:S.HRG.117-836

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available